Experimental and clinical studies have revealed an increased expression of urotensin II in animals with experimentally induced myocardial infarction and diabetes and in patients with diabetes [33, 34], as well as a promotion of cell proliferation and stimulated extra cellular matrix in diabetic animal models [8, 10, 35]. The gene discussed is UTS2; the disease is myocardial infarction.